Foresite Capital Management Iii, LLC Blueprint Medicines Corp Transaction History

Foresite Capital Management Iii, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$66.45 - $92.7 $16.6 Million - $23.1 Million	-249,598 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $4.55 Million - $6.32 Million	79,698 Added 46.91%	249,598 $19.5 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $8.17 Million - $14 Million	169,900 New	169,900 $9.94 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $37.3 Million - $46.2 Million	-559,381 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.9 - $101.41 $6.68 Million - $9.3 Million	91,699 Added 19.61%	559,381 $41.1 Million
Q4 2018 Feb 13, 2019	BUY	$45.57 - $74.26 $12.2 Million - $19.9 Million	267,682 Added 133.84%	467,682 $25.2 Million
Q3 2018 Nov 13, 2018	SELL	$58.91 - $78.32 $2.95 Million - $3.92 Million	-50,000 Reduced 20.0%	200,000 $15.6 Million
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $9.14 Million - $15.2 Million	-150,000 Reduced 37.5%	250,000 $15.9 Million
Q4 2017 Feb 13, 2018	SELL	$62.91 - $88.32 $4.26 Million - $5.98 Million	-67,682 Reduced 14.47%	400,000 $30.2 Million
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $325,486 - $535,204	7,682 Added 1.67%	467,682 $32.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	460,000	460,000 $23.3 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.